Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.

[1]  T. Amagasa,et al.  Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine‐needle aspiration biopsies , 2002, Cancer.

[2]  Xin Huang,et al.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Masuda,et al.  Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. , 2002, Cancer research.

[4]  M. Höglund,et al.  Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21–q29 in head and neck carcinomas , 2002, International journal of cancer.

[5]  Benjamin D. Smith,et al.  Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  D. Slamon,et al.  Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Hung,et al.  β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .

[8]  J. Califano,et al.  Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  I. Petersen,et al.  Chromosomal instability and cytoskeletal defects in oral cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Ferlay,et al.  Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999). , 1999, International journal of cancer.

[11]  R. Sutherland,et al.  Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  J. Ferlay,et al.  Estimates of the worldwide mortality from 25 cancers in 1990 , 1999, International journal of cancer.

[13]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[14]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[15]  W. Hong,et al.  Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification , 1998, Oncogene.

[16]  M. Höglund,et al.  FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q , 1998, Genes, chromosomes & cancer.

[17]  F. Toledo,et al.  A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. , 1998, Molecular cell.

[18]  K. Somers,et al.  Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro , 1998, Oncogene.

[19]  M. Fukumoto,et al.  Cyclin‐D1‐gene amplification is a more potent prognostic factor than its protein over‐expression in human head‐and‐neck squamous‐cell carcinoma , 1997, International journal of cancer.

[20]  F. Toledo,et al.  Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.

[21]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[22]  J. Inazawa,et al.  Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer , 1996, Cancer.

[23]  E. Schuuring.  The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. , 1995, Gene.

[24]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[25]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[26]  Å. Borg,et al.  Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. , 2002, International journal of oncology.

[27]  G. Neri,et al.  Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  A. Balmain,et al.  How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .